Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...

HealthDay News — Psilocybin-assisted therapy (PAT) shows long-term safety and efficacy for treating symptoms of major depressive disorder (MDD), according to a study published online September 4 in ...

As the conversation around mental health disorders like depression becomes increasingly normalized, it can also blur the lines between situational feelings of stress, anxiety, and dejection and ...

Mental health advocates have made great strides in removing the stigma around mental illness and building awareness around the signs and symptoms of major mental health disorders and effective, ...

A ketogenic diet (KD) is a feasible adjunctive therapy and is associated with improvements in depression symptoms among young adults with major depressive disorder (MDD), according to a study ...

Compared with sham therapy, 12 days of personalized treatment with high-definition transcranial direct current stimulation ...

The FDA has granted 510(k) clearance to an Atlanta-based medical technology firm for a transcranial magnetic stimulation ...

AbbVie has agreed to buy bretisilocin, an investigational therapy for major depressive disorder, for up to $1.2 billion in deal that bolsters the biopharmaceutical company's psychiatry pipeline.